The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

The EMA has lifted restrictions on the chikungunya vaccine in people 65 and older, while warning that it should be used only ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 ...

Controversial precautionary rules imposed last year for prescribing valproate to potentially fertile males are being assessed ...

Valneva ( ($VALN) ) just unveiled an update. On July 11, 2025, Valneva announced that the European Medicines Agency (EMA) lifted the temporary ...

At its July meeting, the European Medicines Agency’s pharmacovigilance committee (PRAC) completed its review of French ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

EMA lifts suspension on Valneva's chikungunya vaccine for older adults, emphasizing its importance in high-risk situations.

An experimental drug, Elinzanetant, has shown promise in reducing menopause symptoms in breast cancer patients undergoing ...

An updated edition of the June 4, 2025 article. The world is in the midst of a historic demographic shift with populations ...

The European Commission (EC) has approved Biocon Biologics’ biosimilars referencing Amgen’s bone disease therapy denosumab.

Pharmexcil urges member exporters to respond to Mauritius medicine requirement: Shardul Nautiyal, Mumbai Saturday, July 12, 2025, 08:00 Hrs [IST] The Pharmaceuticals Export Promot ...